AZN vs VYNE · P/E 28, $288.38B cap vs rev $501.0K
AstraZeneca PLC (AZN) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the AZN and VYNE stock pages for the full models.
Not investment advice.